Mental Health Clinics in Delmar, NY Accepting Medicare
9 Mental Health Clinics found. Showing 1 - 9
 Susan Gardiner, Psychiatrist,, P.c. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 785 Delaware Ave, Delmar, NY 12054 Phone: 518-439-1693 |
Capital Area Christian Counseling Asso Psychologist - Counseling Medicare: Medicare Enrolled Practice Location: 196 Delaware Ave, Delmar, NY 12054 Phone: 518-439-0033 Fax: 518-439-7167 |
Hollyhock Psychological Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 423 Kenwood Ave, Delmar, NY 12054 Phone: 518-573-9858 |
Barbara F Pats Phd Psychologist Pllc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 413 Kenwood Ave, Delmar, NY 12054 Phone: 518-439-0090 |
Vincent Psychology Pllc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 274 Delaware Ave Ste 2b, Delmar, NY 12054 Phone: 518-423-5157 |
Online Care Psychology Pc Psychologist Medicare: Not Enrolled in Medicare Practice Location: 26 Oldox Rd, Delmar, NY 12054 Phone: 617-204-3500 |
Benjamin Goitz Mental Health Counseling, Pllc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 125 Adams St Ste 1, Delmar, NY 12054 Phone: 518-407-3291 Fax: 518-475-9846 |
Walk It Out Now Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 5 Fernbank Ave, Delmar, NY 12054 Phone: 518-407-3072 |
Cca Wellness Network Ipa Llc Counselor Medicare: Medicare Enrolled Practice Location: 196 Delaware Ave, Delmar, NY 12054 Phone: 518-439-0033 Fax: 518-439-7167 |
News Archive
FDA grants QIDP and Fast Track designation to Nabriva's lefamulin for treatment of CABP, ABSSSI
Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).
Blocking a protein helps virus to thrive and restore immune function to fight HCV infection
The hepatitis C virus hijacks the body's immune system, leaving T cells unable to function. A new study in animal models suggests that blocking a protein that helps the virus thrive could restore immune function, allowing the body to fight infection. The work, led by teams at The Research Institute at Nationwide Children's Hospital and Emory University, was published online Aug. 26 in the Proceedings of the National Academy of Sciences.
Changes in vaginal pH make women more susceptible to infections
Changes in vaginal pH as a result of common "pH triggers" make women more susceptible to infections such as bacterial vaginosis (BV). Understanding how the vaginal environment responds to pH fluctuation helps health professionals prevent and treat these conditions.
Role of statin therapy in patients with heart failure
An advanced study launched at Yale School of Medicine is evaluating the role of statin therapy in patients with heart failure, one of the leading causes of hospitalization in people over age 65.
Janssen Pharmaceutical to invest $10 million in global Dementia Discovery Fund
Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will invest $10 million in a new UK government-led global dementia discovery fund that will support innovative research to help find new ways to prevent and treat dementia and Alzheimer's disease.
› Verified 1 days ago